Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
6.30
+0.23 (3.79%)
At close: Apr 10, 2026, 4:00 PM EDT
6.29
-0.01 (-0.16%)
After-hours: Apr 10, 2026, 4:10 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $144.45 million as of April 10, 2026. Its market cap has decreased by -12.43% in one year.
Market Cap
144.45M
Enterprise Value
23.10M
1-Year Change
-12.43%
Ranking
Category
Stock Price
$6.30
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $144.45M, a decrease of -32.66%. That is a compound annual growth rate of -31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 139.17M | -11.83% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 161.53M |
| Tiziana Life Sciences | 160.81M |
| Nkarta | 160.40M |
| Connect Biopharma Holdings | 159.39M |
| Agenus | 155.90M |
| Immunic | 155.25M |
| Spero Therapeutics | 154.57M |
| Alpha Cognition | 151.55M |